Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. (Q51367598)

4 April 2018

title

Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. (English)

1 reference

4 April 2018

author

Ben Schöttker

1

1 reference

4 April 2018

Hermann Brenner

5

1 reference

4 April 2018

Dietrich Rothenbacher

3

object named as

Dietrich Rothenbacher

1 reference

4 April 2018

Elke Raum

2

1 reference

4 April 2018

Heiko Müller

4

1 reference

4 April 2018

publication date

27 September 2011

1 reference

4 April 2018

European Journal of Epidemiology

published in

1 reference

4 April 2018

volume

26

1 reference

4 April 2018

issue

10

1 reference

4 April 2018

page(s)

779-787

1 reference

4 April 2018

Glucose: a simple molecule that is not simple to quantify

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Alcohol consumption, serum gamma-glutamyltransferase, and helicobacter pylori infection in a population-based study among 9733 older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

The epidemiology of hemoglobin levels in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Hemoglobin A1c in predicting progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Can a screening programme for diabetes be applied to another population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung (ESTHER-Studie)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Sozioökonomische Unterschiede in der Inanspruchnahme von Früherkennungsuntersuchungen und Maßnahmen der Gesundheitsförderung in NRW

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9619-9

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

21 January 2018

1 reference

12 December 2020

Screening for type 2 diabetes: literature review and economic modelling

1 reference

12 December 2020

Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and th

1 reference

12 December 2020

An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes

1 reference

12 December 2020

Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologi

1 reference

12 December 2020

Standards of medical care in diabetes--2011.

1 reference

12 December 2020

HbA1c standardisation: history, science and politics

1 reference

12 December 2020

Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria

1 reference

12 December 2020

HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark.

1 reference

12 December 2020

Standards of medical care in diabetes--2010.

1 reference

12 December 2020

Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.

1 reference

12 December 2020

Accuracy and precision of glucose monitoring are relevant to treatment decision-making and clinical outcome in hospitalized patients with diabetes

1 reference

12 December 2020

10.1007/S10654-011-9619-9

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018